Satyavrat Shukla

Satyavrat Shukla

Nessuna posizione attualmente

Patrimonio netto: 99 149 $ in data 31/08/2026

54 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Satyavrat Shukla worked at Cornerstone Research, Inc. as Principal from 2003 to 2012.
Then worked at Vertex Pharmaceuticals, Inc. as Vice President & Global Head-Corporate Finance from 2012 to 2019.
Worked at Alaunos Therapeutics, Inc. as Chief Financial Officer & Executive Vice President from 2019 to 2020.
Worked at Spero Therapeutics, Inc. as Director in 2025.
Education includes an undergraduate degree from Harvard University in 1993 and an MBA from Yale University in 1999.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
01/04/2026 81.270 ( 0,14% ) 99 149 $ 31/08/2026

Precedenti posizioni note di Satyavrat Shukla

SocietàPosizioneFine
SPERO THERAPEUTICS, INC. Amministratore Delegato 10/01/2025
ALAUNOS THERAPEUTICS, INC. Direttore Finanziario/CFO 31/12/2020
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal 01/07/2019
Corporate Officer/Principal 01/01/2012
Vedi nel dettaglio l'esperienza di Satyavrat Shukla

Formazione di Satyavrat Shukla

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

97

Relazioni di 1° grado

6

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private6

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Satyavrat Shukla